C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2004
12/02/2004	US20040241694 Using expression patter of neurodegenerative marker to diagnose/prognose brain disorders
12/02/2004	US20040241685 Method of analyzing nucleic acid specifying gene showing change in expression dose in schizophrenia
12/02/2004	US20040241684 Directed protein modification by iterative sequence insertion
12/02/2004	US20040241682 Cancer
12/02/2004	US20040241679 Amplifying target sequence in presence of duplex binding agent, polymerase and labeled primer/probe, recovering product and monitoring fluorescence; kits
12/02/2004	US20040241678 Polynucleotide sequencing method
12/02/2004	US20040241676 Using physical map of pig genome to identify mutants in mast/stem cell growth factor receptor (KIT) for use in determining coat color in swine
12/02/2004	US20040241674 Plant synthesizing copolyesters from monomer derived from short-chain fatty acid and process for producing polyesters
12/02/2004	US20040241673 Non-cytotoxic pap mutants
12/02/2004	US20040241672 Library of a collection of cells
12/02/2004	US20040241671 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their us as medicines
12/02/2004	US20040241664 Protein Hydrolysates Enriched In Peptides Having A Carboxy Terminal Proline Residue
12/02/2004	US20040241656 Isolating and purifying of preferential nucleotide sequences biological sample using biocompatible tube comprised of immobilized biopolymers; high throughput assay; genotyping; genomics
12/02/2004	US20040241650 Computer-directed assembly of a polynucleotide encoding a target polypeptide
12/02/2004	US20040241648 Phosphoribosyl pyrophosphate synthetase 1as herbicidal target
12/02/2004	US20040241647 Using aspergillus or trichoderma as bioreactors for expression of heterologous gene expression
12/02/2004	US20040241646 Novel serine protease reagents and methods useful for detecting and treating diseases of the prostate
12/02/2004	US20040241643 Oligonucleotides for detecting infection of human blood; microarrays and disease diagnosis
12/02/2004	US20040241642 Polynucleotide fragments of an infections human endogenous retrovirus
12/02/2004	US20040241641 Monoclonal antibody for prevention and treatment of human immunodeficiency viral infection; immunotherapy
12/02/2004	US20040241640 Internalisation of virus into cells
12/02/2004	US20040241639 Human tachykinin-related splice variants and compositions thereof
12/02/2004	US20040241638 Bacterial polypeptide for use in developing genetic vaccine for prevention and treatment of respiratory system disorders
12/02/2004	US20040241462 organic polymer linker material layer for enhancing the bond between a gold thin layer and a substrate; terminal end of polymer linker material is capable of reacting with substrate and the other end has positive charge capable of interaction with a negative charge of gold colloid
12/02/2004	US20040241188 Isolated rHMPV comprising partial or complete, genome or antigenome having one or more attenuating nucleotide modifications, anda major nucleocapsid protein, a nucleocapsid phosphoprotein; improved qualities relevant to immunogenicity, safety, protective efficacy and breadth of vaccine coverage
12/02/2004	US20040241182 lymphocytes; immunogens; fusion proteins; for treatment/prevention of infection
12/02/2004	US20040241181 Preferentially inducing a more potent CD8+ T cell response to an immunogen by delivering a recombinant simian adenovirus comprising a nucleic acid molecule encoding an immunogen under the control of gene expression regulatory sequences directing expression of the immunogen; HIV; rabies; papilloma virus
12/02/2004	US20040241156 Gene expression inhibition; solid phase synthesis; drug screening; for treating cancer, central nervous system disorders, and chronic obstructive pulmonary disorder
12/02/2004	US20040241144 mixing of synovial fluid and mesenchymal cells for use in tissue engineering; prophylaxis of degenerative joint diseases
12/02/2004	US20040241142 Vectors; human promoter coupling to gene; kill ing cancer cells
12/02/2004	US20040241141 gene delivery using retroviral genetic vectors such that the gene is expressed at sufficient levels and for a sufficient time for prophylaxis of rheumatic diseases in humans or mammals
12/02/2004	US20040241140 Expression vectors able to elicit improved immune response and methods of using same
12/02/2004	US20040241139 viral genes in covalent junction with foreign, genetically engineered genes; ribonucleic acid segments having upstream splicing donors and downstream splicing acceptor signal surrounding the proximal coding regions; vaccines
12/02/2004	US20040241096 Detect enzyme activity in sample; incubation target tissue; detect amplification in sample
12/02/2004	US20040238369 Stepwise chemical synthesis of oligomers such as oligonucleotides
12/02/2004	DE10332117A1 Verfahren zur Herstellung eines Trägers mit immobilisierten Viren und Verwendung eines derartigen Trägers A process for the production of a support immobilized with viruses and the use of such a carrier
12/02/2004	DE10321963A1 Verfahren zur Herstellung eines Plastid-dirigierten Proteins in Pflanzenzellen A method for producing a plastid-directed protein into plant cells
12/02/2004	CA2526985A1 Method for isolating and cloning high molecular weight polynucleotide molecules from the environment
12/02/2004	CA2526790A1 Method for screening inhibitors of the gamma-secretase
12/02/2004	CA2526493A1 Means for preventing and treating cellular death and their biological applications
12/02/2004	CA2526440A1 Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
12/02/2004	CA2526409A1 Nucleic acid processing methods, kits and devices
12/02/2004	CA2526403A1 New enterovirus, vaccines, medicaments and diagnostic kits
12/02/2004	CA2526397A1 Preparation of endodermal stem cells
12/02/2004	CA2526393A1 Antisense oligonucleotides directed to ribonucleotide reductase r1 and uses thereof in the treatment of cancer
12/02/2004	CA2526275A1 Hypoallergenic variants of the parietaria judaica major allergens, uses thereof and compostitions comprising them
12/02/2004	CA2525954A1 Ura5 gene and methods for stable genetic integration in yeast
12/02/2004	CA2525698A1 A nucleic acid construct containing a nucleic acid derived from the genome of hepatitis c virus (hcv) of genotype 2a, and a cell having such nucleic acid construct introduced therein
12/02/2004	CA2525603A1 Methods and compositions for the production of adenoviral vectors
12/02/2004	CA2525304A1 Recombinant gene medicine of adenovirus vector and gene p53 for treating proliferative diseases
12/02/2004	CA2525181A1 Tnf-like secreted protein
12/02/2004	CA2525012A1 Protein kinase c zeta as a drug target for arthritis and other inflammatory diseases
12/02/2004	CA2524936A1 Compositions and methods for the preparation of human growth hormone glycosylation mutants
12/02/2004	CA2524675A1 Markers for lxr activation
12/02/2004	CA2523789A1 Genes encoding carotenoid compounds
12/02/2004	CA2523786A1 A .delta.-12 desaturase gene suitable for altering levels of polyunsaturated fatty acids in oleaginous yeasts
12/01/2004	EP1482434A2 Protein design automation for protein libraries
12/01/2004	EP1482433A2 Protein design automation for protein libraries
12/01/2004	EP1482053A2 Eukaryotic host cell line in which an endogenous gene has been activated, and uses thereof
12/01/2004	EP1482052A1 Modified polypeptides for targeting cell-entry of the adenoviruses of subtype B
12/01/2004	EP1482051A1 Yam-origin chitinase of family 19 and class iv
12/01/2004	EP1482050A1 Enzyme with xylanase activity at acidic ph
12/01/2004	EP1482049A2 A protein tyrosine kinase.
12/01/2004	EP1482048A1 Sulfotransferase, its polypeptide and dna encoding the same
12/01/2004	EP1482047A1 PROTEIN OR POLYPEPTIDE HAVING LACHRYMATOR SYNTHASE ACTIVITY, DNA ENCODING THE PROTEIN OR THE POLYPEPTIDE, PROCESS FOR PRODUCING PROTEIN OR POLYPEPTIDE HAVING LACHRYMATOR SYNTHASE ACTIVITY USING THE DNA, AND NUCLEIC ACID MOLECULE INHIBITING THE TRANSLATION OF mRNA CONCERNING THE PROTEIN OR THE PEPTID
12/01/2004	EP1482046A2 G-CSF analog compositions and methods
12/01/2004	EP1482045A2 G-CSF analog compositions and methods
12/01/2004	EP1482044A2 Multivariant IL-3 hematopoiesis fusion protein
12/01/2004	EP1482043A1 Proteins capable of binding to environmental hormones and process for producing the same
12/01/2004	EP1482042A1 Active and inactive CC-chemokine receptors and nucleic acid molecules encoding said receptor
12/01/2004	EP1482041A1 Nnl6 tie receptor tyrosine kinase ligand homologues
12/01/2004	EP1482040A2 NL3 TIE receptor tyrosine kinase ligand homologues
12/01/2004	EP1482039A1 PRESYNAPTIC PROTEIN p120
12/01/2004	EP1482038A1 Novel protein and dna thereof
12/01/2004	EP1482037A1 Inhibition of gene expression by delivery of specially selected double stranded or other forms of small interfering RNA precursors enabling the formation of small interfering RNA in vivo and in vitro
12/01/2004	EP1482036A2 A method for increasing the concentration of a nucleic acid molecule
12/01/2004	EP1482035A1 Process for producing physiologically active protein using genetically modified silkworm
12/01/2004	EP1482031A1 Serum-free mammalian cell culture medium, and uses thereof
12/01/2004	EP1481992A2 Humanized antibodies that sequester amyloid beta peptide
12/01/2004	EP1481991A1 Allergenic protein of natural rubber
12/01/2004	EP1481990A1 A-33 related antigens and their pharmacological uses
12/01/2004	EP1481989A1 A-33 related antigens and their pharmacological uses
12/01/2004	EP1481987A1 Method for screening inhibitors of the gamma-secretase
12/01/2004	EP1481667A1 NEP inhibitors for the treatment of female sexual dysfunction
12/01/2004	EP1481302A1 Temperature control method and apparatus for driving polymerize chain reaction (pcr) chip
12/01/2004	EP1481251A2 Estrogen receptor interaction with a transcription factor
12/01/2004	EP1481098A1 Compositions and methods for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays
12/01/2004	EP1481096A1 Surface modification, linker attachment, and polymerization methods
12/01/2004	EP1481095A2 Method and nucleic acids for the analysis of colon cell proliferative disorders
12/01/2004	EP1481093A2 MODULATION OF TYPE II&bgr; PHOSPHOINOSITIDE PHOSPHATE KINASE
12/01/2004	EP1481090A1 Methods and reagents for detecting target binding by nucleic acid ligands
12/01/2004	EP1481087A2 Zinc finger libraries
12/01/2004	EP1481085A2 Oligonucleotide analogues and methods of use for modulating gene expression
12/01/2004	EP1481084A2 The use of ribozymes in the detection of adventitious agents
12/01/2004	EP1481083A2 NUCLEIC ACID PROBES, THEIR SYNTHESIS AND USE
12/01/2004	EP1481080A2 Methods for the identification of inhibitors of alpha-aminoadipate reductase and homocitrate synthase as antibiotics
12/01/2004	EP1481075A2 Amino acid-producing bacteria and a process for preparing l-amino acids
12/01/2004	EP1481071A1 Use of early light-inducible proteins (elip) to increase plant resistance to photochemical oxidant stress
12/01/2004	EP1481070A2 Method for generating maize plants with an increased leaf starch content, and their use for making maize silage
12/01/2004	EP1481069A2 Lis promoter for expression of transgenes in floral tissues

1 ... 2126 2127 2128 2129 2130 2131 2132 2133 2134 2135 2136 2137 2138 2139 2140 2141 2142 2143 2144 2145 2146 ... 4023